BlackRock’s NeueHealth NEUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-113,629
| Closed | -$758K | – | 5660 |
|
|
2025
Q3 | $758K | Buy |
113,629
+434
| +0.4% | +$2.92K | ﹤0.01% | 4372 |
|
|
2025
Q2 | $781K | Buy |
113,195
+1,105
| +1% | +$7.43K | ﹤0.01% | 4336 |
|
|
2025
Q1 | $758K | Buy |
112,090
+32,792
| +41% | +$230K | ﹤0.01% | 4271 |
|
|
2024
Q4 | $588K | Sell |
79,298
-2,661
| -3% | -$14.1K | ﹤0.01% | 4366 |
|
|
2024
Q3 | $428K | Buy |
81,959
+3,309
| +4% | +$17.5K | ﹤0.01% | 4369 |
|
|
2024
Q2 | $428K | Buy |
78,650
+6,037
| +8% | +$35.9K | ﹤0.01% | 4384 |
|
|
2024
Q1 | $472K | Buy |
72,613
+27,557
| +61% | +$246K | ﹤0.01% | 4383 |
|
|
2023
Q4 | $344K | Buy |
45,056
+96
| +0.2% | +$645 | ﹤0.01% | 4519 |
|
|
2023
Q3 | $268K | Buy |
44,960
+709
| +2% | +$7.29K | ﹤0.01% | 4595 |
|
|
2023
Q2 | $541K | Sell |
44,251
-140,645
| -76% | -$1.86M | ﹤0.01% | 4462 |
|
|
2023
Q1 | $3.26M | Buy |
184,896
+7,966
| +5% | +$411K | ﹤0.01% | 3825 |
|
|
2022
Q4 | $9.2M | Buy |
176,930
+8,845
| +5% | +$643K | ﹤0.01% | 3436 |
|
|
2022
Q3 | $14.1M | Buy |
168,085
+37,084
| +28% | +$4.92M | ﹤0.01% | 3235 |
|
|
2022
Q2 | $19.1M | Sell |
131,001
-16,491
| -11% | -$2.4M | ﹤0.01% | 3117 |
|
|
2022
Q1 | $22.8M | Buy |
147,492
+114,220
| +343% | +$25.4M | ﹤0.01% | 3095 |
|
|
2021
Q4 | $9.16M | Buy |
33,272
+3,767
| +13% | +$1.74M | ﹤0.01% | 3727 |
|
|
2021
Q3 | $19.3M | Buy |
+29,505
| New | +$26M | ﹤0.01% | 3304 |
|
BlackRock's NEUE Position: Q4 2025 in Review
BlackRock sold out of NeueHealth (NEUE) in Q4 2025, closing a stake of 113,629 shares — an estimated $758K sold.
BlackRock first reported a position in NEUE in Q3 2021 and held it in 17 quarters. The position peaked at $22.8M in Q1 2022. 0 funds tracked by Wall St. Rank hold NEUE as of Q4 2025.
- BlackRock reported no remaining NeueHealth position as of Q4 2025 after selling out during the quarter.
- BlackRock sold 113,629 NeueHealth shares in Q4 2025, an estimated $758K.
- BlackRock first reported a position in NeueHealth in Q3 2021 and held it in 17 quarters.
- BlackRock's NeueHealth position peaked at $22.8M in Q1 2022.
- 0 funds tracked by Wall St. Rank held NeueHealth as of Q4 2025.
Based on BlackRock's 13F filing for Q4 2025, filed 12 Feb 2026.